Oramed Pharmaceuticals has secured $36.9 million in a strategic investment in Alpha Tau Medical to support its cancer therapy technology and commercialization efforts.
Amount Raised
$36.9 Million
Round Type
Corporate Round
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Oramed Pharmaceuticals Inc. has successfully closed a $36.9 million strategic investment in Alpha Tau Medical Ltd. As part of this collaboration, Oramed will provide business strategic guidance and governance. The investment aims to accelerate Alpha Tau's commercialization of its innovative cancer therapy technology
Quick answer
Oratech Pharmaceuticals raised $36.9 Million in a Corporate Round round, dated April 28, 2025. Investors: Oramed Pharmaceuticals Inc. Oratech Pharmaceuticals is based in New York, New York, United States.
- How much did Oratech Pharmaceuticals raise?
- Oratech Pharmaceuticals raised $36.9 Million in a Corporate Round round on April 28, 2025.
- Who invested in Oratech Pharmaceuticals?
- Oramed Pharmaceuticals Inc. is named as investors in this round.
- What does Oratech Pharmaceuticals do?
- Oratech Pharmaceuticals is a subsidiary of Oramed Pharmaceuticals.
- Where is Oratech Pharmaceuticals based and how big is it?
- Oratech Pharmaceuticals is based in New York, New York, United States. Fundz records about 16 employees.
- Who are the decision-makers at Oratech Pharmaceuticals?
- Fundz holds 1 contact at Oratech Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Oratech Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Ensho Therapeutics raised $23M on June 12, 2025.
- Mezzion Pharma raised $20M (Funding Round) on June 11, 2025.
- Paradigm Therapeutics raised $13M (Funding Round) on May 6, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.8M on May 2, 2025.
- Retension Pharmaceuticals raised $12M on April 22, 2025.
- Pathos AI raised $283M on April 17, 2025.
Who to call at Oratech Pharmaceuticals, and when
A new round usually means Oratech Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oratech Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oratech Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oratech Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oratech Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oratech Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.